neuromuscular
disord
increasingli
recogn
complic
patient
intens
care
unit
icu
repres
common
caus
prolong
ventil
depend
distinct
syndrom
critic
ill
myopathi
prolong
neuromuscular
blockad
critic
ill
polyneuropathi
cip
may
aris
consequ
sepsi
multiorgan
failur
exposur
variou
medic
notabl
intraven
corticosteroid
neuromuscular
block
agent
pathophysiolog
disord
remain
poorli
understood
one
syndrom
may
occur
simultan
distinct
may
difficult
particular
patient
specif
diagnosi
usual
establish
care
clinic
electrodiagnost
necessari
histolog
evalu
exampl
asthmat
requir
treatment
corticosteroid
neuromuscular
block
agent
may
develop
acut
myopathi
character
gener
weak
preserv
eye
movement
elev
creatin
kinas
level
myopath
motor
unit
electromyographi
emg
muscl
biopsi
demonstr
distinct
featur
thick
myosin
filament
loss
ultrastructur
studi
convers
prolong
icu
cours
complic
episod
sepsi
failur
wean
ventil
distal
gener
flaccid
limb
weak
areflexia
probabl
cip
emg
patient
demonstr
reduc
absent
motor
sensori
potenti
neurogen
motor
unit
prolong
neuromuscular
blockad
commonli
occur
patient
renal
failur
receiv
prolong
infus
neuromuscular
blocker
sever
flaccid
areflex
paralysi
normal
sensat
facial
weak
ophthalmoparesi
persist
day
week
neuromuscular
blocker
discontinu
repetit
nerv
stimul
show
decrement
compound
muscl
action
potenti
case
establish
disord
neuromuscular
transmiss
recent
epidem
west
nile
viru
infect
clinic
syndrom
acut
flaccid
paralysi
sever
featur
indistinguish
poliomyel
emerg
articl
critic
examin
clinic
electrophysiolog
patholog
featur
acut
neuromuscular
syndrom
aris
context
icu
care
summar
current
understand
pathophysiolog
treatment
disord
gener
weak
critic
ill
patient
frequent
complic
intens
care
unit
icu
common
caus
prolong
ventil
depend
neurocrit
care
volum
complet
understood
addit
neuromuscular
ill
often
requir
icu
manag
eg
guillain
syndrom
gb
myasthenia
gravi
acut
flaccid
paralysi
complic
west
nile
viru
articl
emphas
sever
distinct
neuromuscular
syndrom
may
aris
de
novo
patient
icu
specif
critic
ill
myopathi
cim
also
term
acut
steroid
myopathi
acut
quadripleg
myopathi
prolong
neuromuscular
blockad
critic
ill
polyneuropathi
cip
although
sever
use
review
condit
recent
appear
give
impress
etiolog
syndrom
well
understood
process
mutual
exclus
mani
accept
case
literatur
uncrit
add
notion
one
syndrom
may
occur
simultan
distinct
may
difficult
particular
patient
specif
diagnosi
usual
establish
care
clinic
laboratori
electrodiagnost
histopatholog
evalu
use
clinician
consid
neurolog
disord
caus
paralysi
prior
icu
admiss
contrast
weak
develop
establish
patient
icu
tabl
critic
care
physician
anesthesiologist
long
recogn
syndrom
sever
gener
weak
associ
corticosteroid
neuromuscular
blocker
nmb
subsequ
attribut
acut
myopathi
macfarlan
rosenth
first
report
ill
asthmat
becam
quadripleg
treatment
larg
dose
hydrocortison
g
hour
pancuronium
least
addit
review
detail
clinic
featur
similar
patient
condit
various
describ
acut
hydrocortison
myopathi
acut
quadripleg
myopathi
necrot
myopathi
thick
filament
myopathi
postparalysi
syndrom
acut
myopathi
intens
care
cim
mani
report
consid
myopathi
acut
effect
corticosteroid
alon
evid
suggest
nmb
possibl
factor
eg
sepsi
trauma
medic
signific
role
ambigu
term
cim
seem
prefer
origin
limit
better
elucid
major
patient
cim
exacerb
acut
asthma
emphysema
requir
treatment
highdos
intraven
steroid
mechan
ventil
disord
also
describ
patient
sever
acut
respiratori
distress
syndrom
hand
report
case
also
receiv
nmb
patient
cim
icu
persist
moder
sever
flaccid
gener
weak
becom
appar
nmb
discontinu
tabl
unlik
myopathi
predilect
proxim
muscl
distal
proxim
muscl
may
affect
equal
distal
weak
occasion
predomin
limb
tone
reduc
time
muscl
becom
atroph
weak
usual
symmetr
rare
may
begin
one
limb
reflex
may
normal
reduc
absent
latter
atyp
myopathi
preserv
sensat
usual
help
differenti
myopathi
cip
discuss
later
occur
simultan
confound
clinic
evalu
ophthalmoparesi
ptosi
facial
weak
report
least
five
patient
lead
diagnost
confus
suggest
presenc
prolong
neuromuscular
blockad
recent
studi
suggest
facial
weak
may
present
half
patient
promin
icu
problem
delay
wean
caus
diaphragmat
intercost
muscl
weak
patient
ventilatori
failur
present
symptom
patient
recov
week
report
patient
remain
weak
month
rare
recoveri
incomplet
least
patient
die
medic
complic
cim
report
children
infant
syndrom
virtual
ident
describ
adult
laboratori
evalu
fail
demonstr
caus
acut
gener
weak
hypokalemia
hypophosphatemia
hypermagnesemia
although
serum
creatin
kinas
ck
concentr
usual
increas
least
three
time
normal
frequent
may
higher
least
patient
welldocu
case
normal
ck
level
throughout
hospit
prospect
studi
ck
peak
occur
averag
day
exposur
steroid
nmb
level
remain
elev
approxim
day
indic
increas
ck
valu
may
miss
measur
later
ill
ck
markedli
elev
may
myoglobinuria
renal
failur
electrophysiolog
studi
use
establish
myopath
natur
disord
compound
muscl
action
potenti
cmap
low
amplitud
affect
limb
cmap
may
near
normal
weak
mild
convers
greatli
reduc
cmap
may
also
observ
termin
motor
axon
neuropathi
confound
import
distinct
cip
see
critic
ill
polyneuropathi
unless
patient
concurr
polyneuropathi
sensori
nerv
potenti
preserv
although
sensori
nerv
studi
may
limit
limb
edema
critic
ill
patient
technic
factor
relat
perform
electrodiagnost
studi
icu
set
therefor
absenc
sensori
nerv
action
potenti
exclud
cim
motor
nerv
conduct
veloc
distal
latenc
usual
normal
near
normal
direct
muscl
stimul
recent
describ
techniqu
may
use
differenti
cip
cim
patient
cim
muscl
electr
inexcit
follow
direct
stimul
contrast
denerv
muscl
normal
electr
respons
direct
muscl
stimul
despit
absent
markedli
reduc
distal
cmap
amplitud
follow
nerv
stimul
therefor
ratio
cmap
amplitud
evok
nerv
stimul
evok
direct
muscl
stimul
suggest
myopathi
greater
consist
neuropathi
less
techniqu
subsequ
valid
trojaborg
colleagu
found
nerv
cmap
muscl
cmap
ratio
greater
patient
cim
icu
expect
motor
unit
potenti
small
short
durat
polyphas
normal
earli
recruit
typic
featur
myopathi
one
studi
demonstr
quantit
motor
unit
analysi
show
mean
motor
unit
durat
less
control
motor
unit
number
estim
normal
consist
myopathi
advanc
techniqu
may
distinguish
myopath
neurogen
motor
unit
patient
sever
weak
may
unabl
recruit
motor
unit
analysi
furthermor
direct
muscl
stimul
compar
muscl
nerv
histopatholog
obtain
tissu
biopsi
myopath
neuropath
featur
frequent
coexist
needl
electromyographi
emg
examin
show
variabl
amount
abnorm
spontan
activ
fibril
potenti
weak
muscl
case
cim
fibril
potenti
usual
indic
nerv
diseas
believ
reflect
muscl
fiber
necrosi
caus
function
disconnect
motor
endplat
muscl
fiber
membran
fibril
potenti
diagnost
use
usual
seen
earlier
ie
within
day
onset
weak
cim
neurogen
disord
cip
decrement
amplitud
cmap
follow
repetit
nerv
stimul
twitch
tension
studi
trainoffour
tof
except
occur
patient
emg
studi
perform
soon
onset
paralysi
demonstr
residu
neuromuscular
blockad
juxtapos
myopathi
cim
improv
cmap
amplitud
serial
test
parallel
clinic
recoveri
muscl
power
fibril
potenti
myopath
motor
unit
may
persist
week
month
followup
studi
usual
normal
patient
make
full
recoveri
combin
natur
defect
found
emg
mani
patient
clinic
featur
cim
emphas
complex
case
difficulti
interpret
materi
literatur
exampl
one
prospect
studi
indic
case
would
misclassifi
cip
muscl
biopsi
show
featur
myopathi
anoth
seri
patient
sensorimotor
polyneuropathi
motor
syndrom
direct
muscl
stimul
demonstr
myopath
pattern
patient
neuropath
pattern
patient
wherea
muscl
biopsi
demonstr
mix
neurogen
myopath
featur
patient
nerv
biopsi
show
sensori
axon
neuropathi
patient
cim
report
methylprednisolon
hydrocortison
prednison
betamethason
dexamethason
although
small
studi
shee
suggest
myopathi
associ
cumul
steroid
dose
confirm
other
minimum
dose
durat
steroid
treatment
requir
produc
cim
difficult
estim
variou
confound
factor
includ
differ
rout
administr
intermitt
treatment
schedul
differ
drug
formul
dosag
variou
studi
publish
report
includ
durat
steroid
treatment
cim
report
treatment
dosag
low
mgday
prednison
day
although
must
rather
uncommon
dosag
durat
treatment
welldocu
major
patient
receiv
g
hydrocortison
methylprednisolon
week
similar
difficulti
prevent
accur
estim
minimum
dose
durat
nmb
treatment
requir
induc
myopathi
pancuronium
vecuronium
drug
often
associ
cim
atracurium
nmb
report
caus
similar
syndrom
nmb
dosag
rang
singl
bolu
almost
g
administ
continu
infus
week
howev
mani
case
lack
adequ
document
clinic
syndrom
one
biopsydocu
case
cim
occur
mg
pancuronium
administ
less
day
patient
develop
cim
receiv
mg
nmb
douglass
colleagu
found
patient
cim
receiv
significantli
greater
amount
vecuronium
compar
asthmat
patient
develop
myopathi
unknown
whether
signific
order
drug
administ
nmb
corticosteroid
frequent
administ
concurr
report
cim
provid
detail
sequenc
drug
administr
rel
contribut
nmb
corticosteroid
develop
cim
remain
unsettl
exampl
barohn
cowork
conclud
cim
primarili
relat
steroid
nmb
other
suggest
oppos
view
ad
confus
numer
patient
report
recov
discontinu
nmb
highdos
steroid
maintain
slowli
taper
sever
patholog
confirm
report
cim
associ
steroid
alon
show
characterist
myosin
deplet
without
scatter
necrosi
sever
vacuol
fiber
regener
also
characterist
cim
least
case
cim
relat
exposur
nmb
without
steroid
four
other
myopath
biopsi
detail
provid
zochodn
associ
convincingli
report
three
patient
elev
ck
level
unequivoc
myopath
emg
studi
biopsi
perform
convers
other
report
small
seri
patient
cim
associ
sepsi
multiorgan
failur
without
exposur
nmb
steroid
major
experiment
see
cim
pathogenesi
clinic
evid
suggest
combin
nmb
steroid
requir
produc
cim
case
occasion
ident
syndrom
occur
either
drug
alon
consequ
factor
includ
sepsi
histopatholog
cim
distinct
muscl
biopsi
show
myopath
featur
rang
type
ii
fiber
atrophi
necrosi
ref
figur
frequent
atrophi
fiber
type
muscl
fiber
necrosi
variabl
rang
mild
scatter
necrosi
isol
muscl
fiber
sever
widespread
necrosi
affect
fiber
type
inflammatori
cell
absent
studi
demonstr
class
major
histocompat
complex
product
membran
attack
complex
express
surfac
membran
fiber
small
perivascular
inflammatori
cell
infiltr
express
proinflammatori
cytokin
impli
possibl
inflammatori
compon
case
adenosin
triphosph
atp
ase
stain
often
demonstr
extens
central
pallor
lack
stain
fiber
type
myofibrillar
architectur
often
disrupt
muscl
fiber
vacuol
vacuol
take
usual
histochem
stain
appear
repres
expand
intermyofibrillar
space
examin
electron
microscopi
may
increas
subsarcolemm
pool
glycogen
fat
droplet
fetal
myosin
increas
proport
myofib
consist
muscl
fiber
regener
ultrastructur
studi
demonstr
distinct
featur
cim
select
loss
thick
myosin
filament
ref
figur
b
promin
consist
find
cim
associ
exposur
corticosteroid
nmb
corticosteroid
alon
immunofluoresc
studi
demonstr
muscl
protein
eg
actin
troponin
maintain
other
shown
absenc
myosin
messeng
rna
patholog
specimen
acut
ill
normal
express
recoveri
howev
deplet
thick
myosin
filament
also
occur
sever
congenit
myopathi
dermatomyos
hiv
infect
disord
allozi
et
al
other
report
thick
filament
loss
patient
develop
myopathi
lung
liver
transplant
whether
disord
repres
variant
cim
remain
establish
virtual
patholog
specimen
obtain
random
needl
open
muscl
biopsi
unknown
whether
thick
filament
deplet
patchi
diffus
abnorm
nonetheless
distinct
find
use
clinician
justifi
muscl
biopsi
electron
microscop
examin
diagnosi
uncertain
sander
cowork
show
mani
case
would
misclassifi
cip
base
clinic
emg
paramet
electron
microscopi
muscl
confirm
thick
filament
loss
case
cip
exclud
normal
sural
nerv
biopsi
sever
patient
sever
neartot
paralysi
flaccid
areflexia
profus
fibril
potenti
markedli
elev
ck
myoglobinuria
acut
renal
failur
attribut
diffus
muscl
necrosi
compar
rhabdomyolysi
muscl
biopsi
show
patchi
myofib
necrosi
patient
patient
receiv
vari
combin
steroid
nmb
particularli
vecuronium
one
studi
also
multiorgan
failur
sepsi
prolong
ventil
depend
incomplet
recoveri
typic
patient
group
sever
die
sepsi
medic
complic
although
ramsay
cowork
propos
acut
necrot
myopathi
patient
icu
might
distinguish
high
ck
level
sever
necrosi
muscl
biopsi
wors
prognosi
certain
whether
clinic
electrophysiolog
patholog
featur
suffici
distinct
warrant
differenti
case
cim
evid
suggest
cim
heterogen
condit
sever
differ
pathogen
pathway
may
converg
produc
sever
myopathi
patient
icu
one
explan
suggest
direct
myotox
effect
combin
steroid
nmb
duboi
almon
observ
increas
number
glucocorticoid
receptor
cytosol
denerv
gastrocnemiu
muscl
rat
enhanc
express
steroid
receptor
denerv
muscl
potenti
increas
myofib
vulner
corticosteroid
injuri
anoth
anim
model
dexamethason
compar
dose
employ
human
therapeut
inject
rat
follow
denerv
gastrocnemiu
muscl
produc
select
loss
thick
myosin
filament
reduc
muscl
twitch
amplitud
similarli
abnorm
observ
human
cim
chang
observ
follow
either
denerv
steroid
treatment
alon
other
replic
find
demonstr
myosin
deplet
revers
reinnerv
discontinu
corticosteroid
importantli
withdraw
dexamethason
alon
suffici
allow
recoveri
reinnerv
requir
revers
loss
thick
filament
time
recoveri
anim
model
similar
clinic
cours
observ
patient
cim
glucocorticoid
shown
activ
atpubiquitindepend
proteolyt
system
fast
state
minetti
associ
demonstr
two
patient
cim
one
expos
steroid
one
treat
steroid
nmb
ubiquitin
activ
myosin
degrad
suggest
ubiquitinmedi
pathway
may
play
role
proteolysi
muscl
fiber
atrophi
cim
other
demonstr
overexpress
ubiquitin
caspas
calpain
catabol
enzym
involv
protein
degrad
along
induct
transform
growth
factorb
mitogenactiv
protein
kinas
pathway
muscl
biopsi
materi
suggest
abnorm
calcium
homeostasi
apoptosi
role
pathogenesi
myosin
loss
ill
investig
postul
twohit
hypothesi
explain
etiolog
cim
steroid
may
act
catabol
novel
way
upregul
glucocorticoid
receptor
result
function
denerv
produc
nmb
prolong
immobl
may
contribut
factor
confirm
concept
demonstr
case
report
panegyr
associ
wherein
myasthen
patient
markedli
elev
acetylcholin
receptor
antibodi
develop
acut
sever
myopathi
follow
treatment
highdos
methylprednisolon
muscl
biopsi
show
select
deplet
thick
filament
postul
similar
function
denerv
instanc
caus
acetylcholin
receptor
antibodi
render
skelet
muscl
suscept
myotox
effect
corticosteroid
altern
hypothesi
suggest
alter
muscl
membran
rest
potenti
ion
channel
inactiv
reduc
conduct
perhap
induc
highdos
corticosteroid
administr
effect
combin
muscl
denerv
steroid
exposur
previous
note
rich
colleagu
report
muscl
membran
inexcit
follow
direct
muscl
stimul
patient
cim
postul
patient
cim
abnorm
regul
muscl
protein
express
stabil
aberr
depolar
rest
muscl
membran
potenti
result
abnorm
regul
chlorid
sodium
channel
reduc
sodium
conduct
depolar
muscl
membran
could
inactiv
sodium
channel
thu
produc
muscl
inexcit
observ
acut
corti
co
steroid
administr
decreas
muscl
fiber
conduct
veloc
possibl
chang
intracellular
ion
concentr
support
view
anim
model
cim
demonstr
muscl
fiber
expos
highdos
corticosteroid
becam
inexcit
hyperpolar
shift
voltag
depend
fast
inactiv
sodium
channel
anoth
theori
suggest
cim
reflect
catabol
disord
muscl
occur
consequ
sepsi
releas
cytokin
proinflammatori
substanc
lead
muscl
protein
degrad
hypermetabol
critic
ill
patient
icu
lead
catabol
state
subsequ
muscl
wast
weak
condit
known
cachect
myopathi
natur
disord
welldefin
nerv
conduct
studi
emg
ck
level
normal
muscl
biopsi
may
either
normal
show
type
ii
fiber
atrophi
consist
disus
atrophi
moreov
hypothesi
explain
occurr
cim
nonsept
patient
specif
therapi
cim
beyond
support
care
seem
prudent
avoid
nmb
agent
patient
taper
corticosteroid
rapidli
condit
allow
prognosi
gener
favor
mild
limb
weak
usual
recov
wean
ventil
support
within
day
week
stop
corticosteroid
nmb
agent
patient
sever
weak
often
recov
sever
week
month
although
acut
rehabilit
strategi
seem
intuit
wellperform
studi
indic
aggress
physic
therapi
hasten
recoveri
rhabdomyolysi
may
caus
weak
critic
ill
patient
common
caus
includ
muscl
trauma
usual
crush
injuri
ischemia
larg
muscl
compart
arteri
compress
occlus
sepsi
occasion
medic
toxic
ingest
exampl
acut
necrot
myopathi
complic
treatment
cyclosporin
transplant
patient
icu
may
develop
exposur
zidovudin
patient
aid
patient
rhabdomyolysi
sever
muscl
pain
vari
degre
gener
weak
complet
paralysi
rare
muscl
usual
tender
upon
palpat
may
appear
swollen
markedli
elev
ck
level
may
lead
myoglobinuria
renal
failur
treatment
support
includ
discontinu
treatment
offend
agent
hydrat
alkal
urin
myoglobinuria
present
pain
control
rare
patient
undiagnos
myopathi
may
develop
acut
respiratori
failur
requir
icu
manag
occasion
decompens
rapid
preclud
prompt
recognit
underli
condit
numer
report
respiratori
failur
initi
manifest
acid
maltas
defici
polymyos
dermatomyos
mitochondri
myopathi
myoton
dystrophi
patient
latter
condit
particular
may
develop
progress
weak
respiratori
decompens
gener
anesthesia
minor
surgic
procedur
occasion
patient
polymyos
dermatomyos
fulmin
present
rapidli
progress
gener
weak
sever
myalgia
inflammatori
myopathi
may
encount
icu
includ
acut
viral
myositi
acut
alcohol
myopathi
hiv
myopathi
sarcoid
myopathi
prolong
neuromuscular
blockad
occur
synapt
transmiss
remain
impair
weak
persist
nmb
discontinu
durat
prolong
difficult
defin
may
brief
minut
hour
singl
dose
clinic
import
postop
patient
extub
icu
set
prolong
neuromuscular
blockad
typic
occur
repeat
bolus
continu
infus
nmb
result
persist
weak
even
drug
stop
durat
weak
report
case
rang
littl
hour
long
day
estim
determin
time
clinic
recoveri
direct
assess
neuromuscular
function
probabl
confound
process
poor
cooper
result
sedat
encephalopathi
medic
effect
pain
presenc
cim
cip
report
weak
attribut
prolong
neuromuscular
blockad
includ
detail
emg
studi
muscl
nerv
biopsi
exclud
disord
serial
assess
neuromuscular
transmiss
routin
perform
therefor
difficult
critic
evalu
mani
case
distinct
cip
cim
disord
becom
uncertain
patient
requir
nmb
facilit
mechan
ventil
manag
increas
intracrani
pressur
reduc
muscl
contract
associ
tetanu
drug
overdos
statu
neurocrit
care
volum
epilepticu
elimin
movement
interfer
diagnost
therapeut
procedur
perform
bedsid
pancuronium
vecuronium
atracurium
commonli
use
nmb
critic
care
set
agent
compet
acetylcholin
bind
subunit
postsynapt
receptor
concentr
motor
endplat
pancuronium
vecuronium
aminosteroid
compound
may
myotox
previous
discuss
especi
combin
corticosteroid
fewer
report
neuromuscular
complic
atracurium
benzylisoquinolinium
compound
although
may
explain
less
frequent
use
prolong
neuromuscular
blockad
first
describ
patient
renal
failur
treat
gallamin
experienc
paralysi
day
drug
discontinu
subsequ
report
patient
develop
syndrom
icu
paralyz
nmb
least
day
treat
day
receiv
nmb
week
drug
discontinu
flaccid
areflex
quadriplegia
persist
often
ptosi
ophthalmoplegia
preserv
eye
movement
ophthalmoplegia
rare
cim
cip
almost
alway
signifi
prolong
neuromuscular
blockad
tabl
sever
affect
patient
may
spontan
respir
wherea
other
mild
gener
weak
unabl
wean
ventil
support
sensat
normal
absenc
cip
paralysi
sometim
revers
neostigmin
edrophonium
effect
transient
weak
resolv
sever
day
patient
persist
long
week
virtual
patient
recov
complet
protract
recoveri
probabl
reflect
cim
cip
erron
attribut
prolong
neuromuscular
blockad
process
report
children
infant
predispos
factor
associ
prolong
neuromuscular
blockad
delin
initi
report
suggest
associ
cumul
dosag
nmb
durat
treatment
one
studi
fail
confirm
associ
critic
ill
patient
administ
vecuronium
develop
prolong
neuromuscular
blockad
neglig
vecuronium
level
prolong
paralysi
high
concentr
vecuronium
metabolit
known
vecuronium
metabolit
neuromuscular
block
potenc
vecuronium
believ
accumul
patient
renal
failur
associ
renal
failur
prolong
neuromuscular
blockad
previous
describ
segredo
colleagu
suggest
factor
also
link
prolong
neuromuscular
blockad
includ
femal
gender
acidosi
hypermagnesemia
electrophysiolog
evalu
perform
one
patient
studi
patient
muscl
nerv
biopsi
possibl
remain
cip
cim
contribut
weak
patient
report
mani
patient
also
receiv
corticosteroid
factor
known
prolong
durat
nmb
critic
ill
patient
includ
advanc
age
hepat
failur
certain
medic
eg
aminoglycosid
cyclosporin
clindamycin
lidocain
electrolyt
abnorm
combin
nmb
differ
structur
class
aminosteroid
benzylisoquinolinium
possibl
concurr
sepsi
one
studi
demonstr
recoveri
time
faster
continu
infus
pancuronium
compar
intermitt
bolu
inject
emg
studi
ill
confirm
disord
neuromuscular
transmiss
case
exclud
myopathi
neuropathi
repetit
nerv
stimul
hz
show
characterist
decrement
amplitud
cmap
reflect
diminish
acetylcholin
bind
postsynapt
receptor
decrement
basi
reduct
twitch
amplitud
follow
tof
stimul
howev
repetit
nerv
stimul
rel
insensit
establish
neuromuscular
junction
disord
exampl
decrement
respons
observ
twothird
patient
gener
myasthenia
gravi
furthermor
correl
abnorm
tof
repetit
nerv
stimul
studi
recent
studi
indic
tof
monitor
lead
improv
recoveri
time
lower
nmb
dose
compar
clinic
assess
singlefib
emg
techniqu
greater
sensit
neuromuscular
transmiss
disord
highli
special
timeconsum
deriv
techniqu
stimul
singlefib
emg
requir
patient
cooper
still
painstak
wide
use
icu
set
cmap
amplitud
usual
low
conduct
veloc
distal
latenc
normal
mildli
abnorm
neuromuscular
blockad
complet
cmap
may
absent
thu
simul
neuropathi
howev
sensori
potenti
normal
needl
examin
show
diffus
fibril
potenti
reflect
pharmacolog
denerv
patholog
studi
patient
prolong
neuromuscular
blockad
immatur
neuromuscular
junction
poor
postsynapt
differenti
short
unbranch
junction
fold
shallow
secondari
cleft
observ
muscl
biopsi
two
patient
prolong
weak
follow
neuromuscular
blockad
pretermin
motor
axon
normal
excess
sprout
intramuscular
nerv
muscl
biopsi
obtain
infant
persist
weak
follow
pancuronium
administr
demonstr
enlarg
axon
termin
defici
acetylcholin
vesicl
engorg
organel
neurofila
onehalf
presynapt
axon
sever
atroph
weak
case
attribut
revers
termin
motor
axonopathi
concept
resolv
impli
nerv
damag
neuropathi
discuss
later
role
corticosteroid
patient
prolong
neuromuscular
blockad
controversi
asid
immunolog
catabol
effect
corticosteroid
direct
action
neuromuscular
junction
miniendpl
potenti
constantli
elicit
leakag
acetylcholin
synaps
increas
frequenc
decreas
amplitud
presenc
steroid
suggest
steroid
preand
postsynapt
effect
reduct
amplitud
may
caus
failur
reach
threshold
requir
action
potenti
therebi
impair
neuromuscular
transmiss
effect
may
also
explain
reason
patient
myasthenia
gravi
worsen
transient
initi
highdos
steroid
treatment
fact
miller
et
al
other
demonstr
steroid
directli
impair
neuromuscular
transmiss
patient
myasthenia
gravi
howev
schwartz
associ
show
steadyst
twitch
tension
adductor
pollici
remain
unchang
corticosteroid
administ
periop
patient
receiv
nmb
conclud
steroid
interact
nmb
convers
corticosteroid
shown
potenti
antagon
pancuroniuminduc
neuromuscular
blockad
anim
studi
one
anim
model
kindler
colleagu
demonstr
methylprednisolon
inhibit
muscletyp
nicotin
acetylcholin
receptor
effect
potenti
follow
combin
applic
vecuronium
corticosteroid
howev
patient
receiv
high
dose
vecuronium
without
corticosteroid
substanti
upregul
number
acetylcholin
receptor
indic
exposur
nmb
agent
alon
induc
morpholog
chang
muscl
membran
well
function
denerv
furthermor
direct
clinic
evid
steroid
independ
contribut
impair
neuromuscular
transmiss
patient
icu
administ
nmb
current
must
conclud
steroid
may
limit
influenc
potenti
neuromuscular
blockad
icu
investig
suggest
main
clinic
emg
featur
patient
prolong
neuromuscular
blockad
indic
locu
damag
distal
axon
rather
neuromuscular
junction
especi
patient
normal
repetit
stimul
preserv
sensori
potenti
assert
probabl
relat
insensit
repetit
stimul
test
confus
prolong
neuromuscular
blockad
subtl
cip
cim
patient
prolong
weak
relat
distal
motor
axonopathi
probabl
repres
variant
cip
despit
rel
insensit
repetit
nerv
stimul
practic
method
detect
prolong
neuromuscular
blockad
icu
cmap
elicit
clinic
affect
limb
repetit
stimul
tof
remain
best
method
establish
diagnosi
monitor
recoveri
absenc
decrement
respons
diagnosi
prolong
neuromuscular
blockad
remain
doubt
american
colleg
critic
care
medicin
recent
provid
clinic
practic
guidelin
use
nmb
agent
adult
guidelin
includ
specif
indic
use
nmb
manag
ventil
increas
intracrani
pressur
treat
muscl
spasm
etc
intervent
fail
b
pancuronium
gener
prefer
agent
patient
vagolyt
effect
drug
contraind
eg
cardiac
diseas
signific
hepat
renal
diseas
cisatracurium
atracurium
recommend
c
tof
use
regularli
monitor
degre
blockad
goal
adjust
dosag
produc
one
two
muscl
twitch
sed
analges
use
liber
conjunct
nmb
agent
e
everi
effort
made
discontinu
nmb
agent
patient
treat
corticosteroid
f
drug
holiday
daili
attempt
stop
nmb
agent
condit
patient
requir
use
previous
note
virtual
patient
eventu
recov
prolong
nmb
offend
agent
discontinu
prolong
paralysi
lead
longer
icu
stay
possibl
increas
risk
patient
develop
cim
cip
patient
myasthenia
gravi
condit
develop
acceler
explos
fashion
day
week
lead
sever
limb
oropharyng
weak
ventilatori
failur
patient
requir
close
monitor
rapid
reduct
vital
capac
cckg
indic
intub
mechan
ventil
occasion
patient
undiagnos
myasthenia
gravi
anoth
condit
eg
pneumonia
trauma
etc
requir
icu
manag
ventil
support
neuromuscular
condit
recogn
patient
fail
wean
ventil
patient
characterist
featur
ptosi
ophthalmoparesi
weak
neck
flexor
limb
muscl
diagnosi
establish
lowfrequ
repetit
nerv
stimul
hz
tensilon
test
demonstr
elev
antiacetylcholin
receptor
antibodi
lambert
eaton
myasthen
syndrom
autoimmun
diseas
autoantibodi
direct
presynapt
voltageg
calcium
channel
motor
termin
neurocrit
care
volum
neuromuscular
junction
major
case
associ
small
cell
lung
cancer
malign
condit
usual
chronic
featur
proxim
weak
dri
mouth
impot
manifest
dysautonomia
areflexia
howev
patient
unrecogn
myasthen
syndrom
present
respiratori
failur
requir
intub
patient
improv
plasma
exchang
pyridostigmin
prednison
botul
rare
condit
begin
cranial
nerv
dysfunct
follow
gener
paralysi
confus
oropharyng
ophthalmoparet
region
variant
gb
ill
usual
begin
hour
day
ingest
neurotoxin
produc
clostridium
botulinum
type
b
e
contamin
food
nausea
vomit
follow
constip
neurolog
symptom
blur
vision
earli
complaint
initi
find
includ
dilat
pupil
paralysi
accommod
ptosi
oropharyng
weak
diaphragmat
weak
ventilatori
failur
common
may
sever
limb
weak
contrast
gb
deep
tendon
reflex
usual
preserv
emg
show
reduc
amplitud
motor
potenti
increment
increas
amplitud
usual
baselin
follow
highfrequ
repetit
nerv
stimul
indic
presynapt
neuromuscular
junction
abnorm
cerebrospin
fluid
csf
normal
detect
botulinum
toxin
serum
contamin
food
sourc
cultur
clostridium
botulinum
stool
confirm
diagnosi
antibiot
especi
aminoglycosid
medic
may
deleteri
effect
neuromuscular
junction
seldom
sole
respons
gener
weak
icu
bolton
colleagu
publish
seri
report
describ
axon
sensorimotor
polyneuropathi
associ
sepsi
multiorgan
failur
term
cip
prospect
studi
patient
icu
least
form
acquir
polyneuropathi
studi
electrophysiolog
half
detect
weak
other
also
confirm
high
frequenc
condit
patient
icu
experi
septic
shock
patient
sever
ill
bacteremia
acidosi
hypoalbuminemia
septic
hypotens
impair
kidney
liver
organ
function
episod
sepsi
resolv
difficulti
wean
result
respiratori
muscl
weak
becam
appar
studi
literatur
bolton
et
al
other
clinic
pictur
emerg
distal
limb
weak
hyporeflexia
flaccid
areflex
quadriplegia
sever
case
ref
tabl
approxim
onethird
patient
retain
reflex
variabl
sensori
deficit
report
result
difficulti
test
critic
ill
ventil
patient
occasion
patient
experienc
mild
facial
weak
ophthalmoparesi
uncommon
sepsi
organ
failur
resolv
neuropathi
often
improv
week
month
patient
mild
moder
neuropathi
experi
complet
recoveri
wherea
sever
affect
patient
residu
probabl
perman
weak
sever
longerterm
followup
studi
demonstr
prognosi
complet
recoveri
favor
initi
report
suggest
zifko
evalu
patient
cip
averag
month
follow
icu
discharg
die
first
year
survivor
persist
neurolog
deficit
reduc
qualiti
life
similarli
anoth
studi
patient
sever
cip
evalu
year
hospit
discharg
experienc
complet
recoveri
remain
patient
die
persist
weak
durat
fever
presum
associ
sepsi
number
day
icu
amount
weight
loss
correl
poor
recoveri
superimpos
entrap
neuropathi
result
inadvert
compress
poor
posit
also
may
contribut
persist
deficit
patient
sever
cip
older
studi
found
strong
correl
sever
neuropathi
durat
ventil
depend
sever
multiorgan
failur
number
differ
organ
involv
howev
other
found
correl
electrophysiolog
abnorm
length
stay
icu
time
ventil
research
suggest
peripher
nervou
system
simpli
anoth
organ
involv
patient
icu
multipl
organ
dysfunct
syndrom
investig
observ
significantli
higher
mortal
patient
cip
compar
patient
icu
similar
apach
iii
score
neuropathi
tabl
featur
critic
ill
polyneuropathi
gener
weak
variabl
sever
mild
distal
leg
weak
sever
quadriplegia
flaccid
limb
muscl
atrophi
distal
sensori
loss
may
difficult
assess
facial
ocular
nerv
gener
spare
ptosi
hyporeflexia
areflexia
reflex
may
obtain
onethird
patient
ventilatori
failur
failur
wean
impair
respiratori
mechan
emg
reduc
absent
motor
sensori
potenti
demyelin
featur
exclud
typic
gb
activ
denerv
poorli
recruit
motor
unit
potenti
normal
configur
earli
find
within
day
week
symptom
onset
poorli
recruit
neurogen
motor
unit
potenti
later
find
detect
month
symptom
onset
cerebrospin
fluid
cell
normal
protein
glucos
nerv
biopsi
axon
loss
inflamm
demyelin
muscl
biopsi
neurogen
atrophi
featur
critic
ill
myopathi
may
also
present
emg
electromyographi
gb
syndrom
neurocrit
care
volum
howev
find
confirm
other
prospect
studi
patient
sepsi
demonstr
patient
cip
requir
ventil
support
addit
day
median
valu
remain
icu
addit
day
remain
hospit
addit
day
compar
patient
without
neuropathi
risk
inhospit
mortal
seven
time
greater
among
patient
cip
risk
factor
link
cip
multivari
analysi
includ
hyperosmol
parenter
nutrit
exposur
nmb
absenc
renal
replac
therapi
anoth
prospect
studi
patient
icu
confirm
risk
cip
associ
higher
apach
iii
score
presenc
system
inflammatori
respons
syndrom
emg
demonstr
reduc
motor
sensori
amplitud
rel
preserv
conduct
veloc
distal
latenc
consist
axon
sensorimotor
polyneuropathi
chang
observ
earli
day
onset
sepsi
icu
admiss
contrast
gb
conduct
block
segment
slow
conduct
veloc
spinal
fluid
protein
normal
slightli
elev
although
facial
nerv
paralysi
uncommon
cip
one
investig
observ
denerv
facial
muscl
almost
half
case
mani
patient
cip
report
pure
motor
axonopathi
preserv
sensori
nerv
action
potenti
howev
exist
pure
motor
form
cip
remain
controversi
absenc
larger
studi
exclud
cim
contemporan
muscl
histopatholog
electrophysiolog
assess
respiratori
system
help
establish
diagnosi
cip
amplitud
cmap
elicit
phrenic
nerv
stimul
greatli
reduc
absent
case
correl
presenc
ventilatori
failur
emg
show
abnorm
spontan
muscl
activ
proxim
distal
limb
muscl
poorli
recruit
motor
unit
togeth
consist
expect
activ
denerv
acut
polyneuropathi
activ
denerv
also
observ
diaphragm
respiratori
muscl
patient
cip
failur
wean
repetit
nerv
stimul
consist
normal
import
find
virtual
exclud
prolong
neuromuscular
blockad
howev
serial
studi
stimul
singlefib
emg
demonstr
abnorm
jitter
acut
denerv
patient
cip
indic
abnorm
termin
motor
axon
patient
recov
sepsi
nerv
conduct
studi
usual
demonstr
improv
compound
muscl
action
potenti
amplitud
reinnerv
chang
sever
month
histolog
studi
nerv
obtain
autopsi
nerv
biopsi
confirm
axon
degener
distal
motor
sensori
nerv
without
inflamm
primari
demyelin
chromatolysi
anterior
horn
cell
degener
dorsal
root
ganglion
cell
also
observ
secondari
phenomena
muscl
shown
denerv
atrophi
occasion
necrot
fiber
vacuol
increas
glycogen
deposit
observ
suggest
concurr
cim
mechan
cip
understood
investig
attribut
nonspecif
effect
alter
microcircul
relat
sepsi
exampl
bolton
colleagu
other
hypothes
proinflammatori
cytokin
includ
tumor
necrosi
factor
tnf
serotonin
histamin
releas
sepsi
increas
microvascular
permeabl
lead
breakdown
blood
nerv
barrier
endoneuri
edema
hypoxia
support
increas
express
eselectin
within
endoneuri
vessel
indic
abnorm
endotheli
cell
activ
may
occur
consequ
sepsi
addit
theori
includ
axon
degener
result
glucoseinduc
phosphat
deplet
parenter
nutrit
subsequ
deplet
highenergi
phosphat
compound
b
damag
neural
microvasculatur
result
oxid
effect
parenter
administ
lipid
c
impair
transport
axon
protein
reduc
transmembran
potenti
toxic
effect
releas
proinflammatori
cytokin
exampl
research
demonstr
tnf
decreas
rest
transmembran
potenti
skelet
muscl
fiber
vitro
induc
muscl
proteolysi
anim
howev
one
studi
fail
show
elev
level
tnf
patient
cip
druschki
et
al
other
present
preliminari
data
identifi
lowmolecularweight
substanc
deriv
sera
patient
cip
substanc
toxic
rat
spinal
motor
neuron
studi
fail
implic
vitamin
nutrit
defici
electrolyt
abnorm
medic
former
explan
persist
weak
patient
icu
determin
sever
cip
correspond
durat
icu
stay
well
serum
glucos
level
previous
note
although
sepsi
multiorgan
failur
close
associ
cip
case
steroid
nmb
may
also
role
one
patient
studi
bolton
et
al
receiv
combin
dexamethason
pancuronium
subsequ
report
group
fail
comment
use
steroid
nmb
other
report
cip
patient
treat
highdos
steroid
nmb
without
sepsi
multiorgan
failur
exampl
op
de
coul
colleagu
report
patient
cip
receiv
nmb
septic
attribut
weak
complic
nmb
patient
heterogen
probabl
includ
case
cip
cim
prolong
neuromuscular
blockad
kupfer
cowork
observ
five
patient
predominantli
motor
neuropathi
two
prolong
neuromuscular
blockad
follow
continu
infus
vecuronium
none
sepsi
multiorgan
failur
surprisingli
one
prospect
studi
patient
icu
fail
show
relationship
cip
sepsi
multiorgan
failur
steroid
nmb
although
mani
author
field
stress
causal
relationship
sepsi
cip
report
investig
suggest
sepsi
invari
requir
exampl
review
case
cip
found
infect
infrequ
primari
diagnosi
icu
admiss
account
slightli
onefourth
patient
probabl
underestim
frequenc
sepsi
occur
icu
admiss
patient
develop
cip
other
care
patient
typic
cip
infect
complic
factor
de
letter
colleagu
note
sepsi
sever
score
greater
patient
cip
compar
patient
without
cip
clinician
will
make
diagnosi
cip
patient
sever
system
ill
multipl
organ
dysfunct
characterist
clinic
electrophysiolog
featur
presenteven
absenc
sepsi
case
gener
weak
confound
variabl
poor
understand
pathophysiolog
cip
deter
clinician
prematur
dismiss
contribut
factor
effect
therapi
cip
howev
group
critic
ill
patient
surgic
icu
intens
insulin
therapi
maintain
blood
glucos
mgdl
substanti
reduc
risk
develop
cip
linear
correl
risk
polyneuropathi
mean
blood
glucos
level
recent
prospect
random
control
trial
show
reduct
frequenc
cip
critic
ill
patient
treat
intens
insulin
therapi
median
number
day
mechan
ventil
number
patient
requir
week
mechan
ventil
also
substanti
reduc
openlabel
trial
intraven
immunoglobulin
ivig
three
patient
show
benefit
anoth
report
indic
frequenc
cip
reduc
septic
patient
administ
ivig
earli
icu
cours
suggest
ivig
may
amelior
prevent
cip
develop
highrisk
septic
patient
mani
larg
seri
patient
gb
contain
small
proport
case
reportedli
occur
surgeri
patient
like
cip
consequ
multiorgan
failur
sepsi
factor
associ
prolong
postop
cours
icu
case
gb
genuin
may
trigger
oper
least
three
welldocu
case
gb
becam
evid
discontinu
nmb
corticosteroid
patient
statu
asthmaticu
two
receiv
larg
dose
hydrocortison
methylprednisolon
one
requir
nmb
day
receiv
steroid
sever
flaccid
areflex
quadriplegia
two
requir
prolong
ventil
support
spinal
fluid
protein
normal
emg
show
conduct
block
tempor
dispers
prolong
distal
latenc
absent
frespons
characterist
acquir
demyelin
polyneuropathi
repetit
nerv
stimul
nerv
muscl
biopsi
perform
immun
natur
process
suggest
improv
two
patient
follow
plasma
exchang
anoth
patient
develop
areflex
quadriparesi
multiorgan
failur
elev
csf
protein
elev
antibodi
prolong
frespons
widespread
denerv
like
axon
variant
gb
notabl
condit
associ
acut
gener
weak
occasion
may
encount
icu
set
patient
acut
intermitt
porphyria
aip
may
develop
neuropathi
resembl
gb
variou
medic
infect
trigger
acut
attack
initi
symptom
includ
vomit
constip
abdomin
pain
seizur
occur
case
delirium
psychiatr
symptom
occur
weak
symmetr
begin
proxim
muscl
arm
syndrom
progress
widespread
weak
develop
patient
hypertens
arrhythmia
featur
dysautonomia
common
cranial
nerv
typic
spare
emg
show
axonopathi
rather
demyelin
thu
differenti
condit
gb
increas
urinari
excret
aminolevulin
acid
porphobilinogen
acut
attack
aip
establish
diagnosi
neuropathi
common
complic
system
vascul
usual
evolv
subacut
fashion
rare
acut
mononeur
multiplex
fulmin
cours
simul
acut
polyneuropathi
polyarter
nodosa
churg
strauss
syndrom
vasculitid
like
caus
rapidli
progress
polyneuropathi
may
associ
multiorgan
involv
especi
renal
pulmonari
insuffici
requir
icu
manag
case
focal
multifoc
onset
sever
pain
lack
cranial
nerv
involv
electrophysiolog
featur
multifoc
axonopathi
distinguish
acut
vasculit
neuropathi
gb
cip
cim
csf
protein
level
normal
vasculit
neuropathi
diagnosi
establish
patholog
evid
vascul
biopsi
materi
isol
diaphragmat
weak
progress
ventilatori
failur
uncommon
variant
amyotroph
later
sclerosi
patient
develop
progress
dyspnea
physic
activ
eventu
lead
breathless
rest
ultim
retent
carbon
dioxid
acut
ventilatori
failur
individu
may
intub
emerg
room
diagnosi
establish
neurologist
consult
day
week
later
patient
fail
wean
ventil
may
mild
oropharyng
limb
weak
find
often
inconsequenti
compar
respiratori
abnorm
patient
intub
rapid
shallow
breath
increas
respiratori
rate
use
accessori
muscl
respir
paradox
movement
chest
wall
abdomen
reduc
vital
capac
tidal
volum
neg
inspiratori
forc
patient
high
risk
aspir
diagnosi
establish
electrodiagnost
studi
show
widespread
activ
denerv
fascicul
chronic
reinnerv
sever
limb
respiratori
muscl
often
muscl
group
clinic
unaffect
amplitud
phrenic
nerv
cmap
usual
reduc
needl
electrod
examin
diaphragm
show
activ
denerv
sensori
potenti
normal
west
nile
viru
wnv
arthropodborn
flaviviru
first
isol
west
nile
region
uganda
subsequ
six
decad
numer
human
epidem
document
middl
east
south
africa
russia
unit
state
viru
first
appear
unit
state
new
york
citi
sinc
spread
westward
wnv
report
three
state
trigger
largest
human
arbovir
enceph
epidem
us
histori
ref
wnv
genom
singlestrand
rna
within
japanes
enceph
antigen
complex
viru
maintain
enzooic
mosquito
bird
mosquito
cycl
thirtyseven
speci
mosquito
shown
harbor
viru
human
infect
occur
follow
bite
culex
speci
socal
bridg
vector
mosquito
feed
bird
human
almost
human
infect
occur
august
septemb
coincid
peak
mosquito
bird
transmiss
howev
yearround
transmiss
possibl
tropic
climat
bird
serv
amplifi
host
spread
infect
new
region
human
epidem
unit
state
tempor
link
prior
high
avian
mortal
total
speci
bird
infect
wnv
crow
blue
jay
especi
suscept
convers
human
hors
consid
deadend
host
lowlevel
brief
durat
viremia
howev
epidem
persontoperson
transmiss
report
blood
transfus
organ
transplant
intrauterin
infect
possibl
breast
milk
infect
also
document
laboratori
personnel
via
inadvert
inocul
human
infect
asymptomat
approxim
infect
individu
develop
west
nile
fever
influenzalik
ill
manifest
high
fever
malais
myalgia
headach
patient
infect
wnv
develop
neurolog
symptom
gender
age
predilect
older
individu
age
year
higher
risk
develop
febril
ill
neurolog
diseas
risk
factor
includ
length
time
spent
outdoor
failur
use
mosquito
repel
presenc
mosquito
home
three
clinic
pattern
neurolog
diseas
wnv
infect
emerg
west
nile
mening
west
nile
enceph
wne
acut
flaccid
paralysi
afp
substanti
overlap
among
syndrom
may
occur
half
patient
wne
new
york
citi
outbreak
experienc
sever
weak
exampl
recent
review
case
wnv
cleveland
ohio
indic
patient
wne
follow
afp
combin
three
pattern
present
featur
wnv
infect
fever
fatigu
alter
mental
statu
occasion
progress
coma
headach
back
limb
pain
associ
system
featur
includ
nausea
abdomin
pain
myalgia
transient
maculopapular
rash
lymphadenopathi
wne
later
develop
afp
weak
usual
begin
within
day
week
hospit
median
durat
icu
admiss
patient
day
isol
afp
present
featur
wnv
infect
case
weak
predilect
proxim
muscl
usual
asymmetr
patient
may
develop
monoplegia
paraplegia
brachial
diplegia
quadriplegia
progress
hour
sever
day
reflex
usual
preserv
brisk
may
absent
clinic
affect
limb
sensat
normal
bladder
dysfunct
occur
case
bulbar
weak
ventilatori
failur
occur
minor
patient
ophthalmoparesi
rare
may
mild
leukocytosi
leukopenia
hyponatremia
frequent
observ
routin
laboratori
studi
usual
normal
csf
studi
show
elev
protein
level
rang
mgdl
lymphocyt
pleocytosi
rang
cellsmm
normal
glucos
level
diagnosi
confirm
detect
igm
antibodi
wnv
serum
csf
igm
antibodi
captur
enzymelink
immunosorb
assay
test
prefer
method
serum
igm
antibodi
may
detect
least
day
follow
acut
infect
serum
igm
antibodi
may
persist
month
longer
therefor
detect
high
titer
may
reflect
previou
infect
unrel
current
ill
head
comput
tomographi
scan
usual
normal
brain
magnet
reson
imag
mri
show
mening
ventricular
enhanc
approxim
onethird
case
mri
spine
may
demonstr
signal
chang
anterior
horn
cell
ref
figur
electrodiagnost
studi
confirm
motor
neuron
disord
case
cmap
reduc
absent
conduct
veloc
distal
motor
latenc
normal
slow
proport
degre
axon
loss
conduct
block
sensori
potenti
almost
alway
normal
needl
electrod
examin
show
fibril
reduc
recruit
segment
myotom
pattern
rare
report
wnv
infect
may
associ
demyelin
featur
suggest
gb
similarli
isol
afp
frequent
misdiagnos
gb
condit
usual
distinguish
absenc
fever
encephalopathi
symmetr
weak
promin
sensori
symptom
gener
areflexia
lack
pleocytosi
csf
promin
demyelin
featur
emg
studi
patient
gb
notabl
sever
rna
virus
produc
neurocrit
care
volum
poliomyel
syndrom
superfici
similar
afp
motor
axon
variant
gb
pathogenesi
afp
unknown
suggest
wnv
similar
polioviru
neurotrop
anterior
horn
cell
spinal
cord
also
observ
monkey
hors
bird
experiment
anim
studi
autopsi
studi
confirm
lymphocyt
infiltr
anterior
horn
cell
cell
strike
loss
motor
neuron
chromatolysi
microgli
nodul
well
detect
viral
antigen
spinal
cord
use
immunohistochem
stain
specif
therapi
afp
treatment
support
highdos
ribavirin
interferon
ifn
effect
wnv
vitro
control
data
human
trial
avail
patient
enceph
cerebellar
involv
one
patient
afp
reportedli
improv
follow
treatment
ifna
ivig
use
anecdot
without
benefit
patient
afp
ongo
clinic
trial
ivig
patient
wne
afp
sponsor
nation
institut
health
recent
studi
suggest
passiv
administr
ivig
contain
antiwnv
antibodi
infect
mice
prevent
reduc
sever
wnv
infect
one
case
report
conclud
highdos
steroid
use
case
fatal
rate
risk
factor
death
includ
older
age
reduc
level
conscious
paralysi
immunosuppress
patient
afp
gener
poor
prognosi
littl
improv
limb
weak
although
patient
may
sever
transient
focal
weak
resolv
complet
within
week
clinician
must
rememb
central
nervou
system
disord
caus
gener
paralysi
may
mimic
neuromuscular
diseas
myelopathi
includ
caus
tumor
compress
trauma
inflamm
myeliti
ischemia
affect
limb
respir
situat
high
cervic
region
initi
stage
reflex
may
mute
spinal
shock
thu
simul
neuromuscular
problem
howev
care
sensori
examin
reveal
spinal
sensori
level
chang
reduc
absent
normal
sensat
clavicl
spinal
cord
diseas
alway
concern
gener
paralysi
includ
facial
muscl
basilar
arteri
occlus
damag
corticospin
fiber
pon
also
caus
gener
paralysi
may
extend
face
eye
movement
patient
risk
factor
stroke
histori
preced
transient
ischem
attack
specif
neurolog
featur
preserv
vertic
gaze
hyperreflexia
presenc
babinski
sign
cim
prolong
neuromuscular
blockad
cip
three
main
neuromuscular
syndrom
produc
prolong
paralysi
patient
icu
one
syndrom
may
occur
simultan
distinct
may
difficult
particular
patient
nonetheless
case
one
process
predomin
precis
neuromuscular
syndrom
usual
delin
care
clinic
electrophysiolog
histolog
evalu
asthmat
gener
weak
receiv
combin
steroid
nmb
like
cim
wherea
patient
prolong
icu
stay
sepsi
multiorgan
failur
failur
wean
ventil
probabl
cip
syndrom
produc
sever
flaccid
areflex
quadriplegia
proxim
weak
preserv
reflex
favor
myopathi
wherea
predomin
distal
weak
object
sensori
loss
areflexia
suggest
cip
ptosi
ophthalmoparesi
occur
prolong
neuromuscular
blockad
rare
cim
cip
impair
sensat
although
difficult
confirm
icu
set
strongli
implic
cip
ck
level
typic
uniformli
elev
myopathi
howev
usual
normal
cip
prolong
neuromuscular
blockad
patient
admit
icu
fever
encephalopathi
follow
asymmetr
flaccid
paralysi
evalu
wnv
infect
electrodiagnost
studi
repetit
nerv
stimul
clarifi
diagnosi
case
indic
patient
icu
experi
unexplain
weak
emg
consid
extens
clinic
examin
specif
electrodiagnost
question
address
direct
muscl
stimul
promis
techniqu
may
distinguish
cip
cim
result
emg
confus
one
process
occur
simultan
situat
muscl
andor
nerv
biopsi
obtain
establish
diagnosi
biopsi
specimen
muscl
nerv
select
base
result
emg
must
interpret
experienc
individu
specif
therapi
neuromuscular
syndrom
attent
necessarili
focus
prevent
exampl
intens
insulin
therapi
maintain
blood
glucos
mgdl
reduc
risk
cip
twitch
monitor
suggest
mandatori
test
patient
receiv
nmb
physician
current
use
techniqu
infrequ
evid
serial
test
tof
prevent
neuromuscular
complic
instead
use
nmb
minim
critic
ill
patient
requir
assist
ventil
manag
adequ
use
shortact
benzodiazepin
midazolam
propofol
analges
fentanyl
morphin
moreov
strong
evid
corticosteroid
administ
concurr
nmb
nmb
necessari
shorter
act
nonsteroid
agent
atracurium
may
prefer
possibl
nmb
discontinu
daili
assess
neurolog
recoveri
continu
infus
prolong
durat
treatment
hour
avoid
tof
monitor
may
prevent
inadvert
overdos
well
excess
neuromuscular
blockad
patient
importantli
clinician
care
critic
ill
patient
must
awar
frequenc
neuromuscular
complic
associ
agent
